The HS-Troponin study: the effect of 5th generation versus 4th generation troponin-based care on patients with acute coronary syndromes(ACS).

Phase 4

Completed

• Conditions: Acute coronary syndromes; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12611000879965
• Lead Sponsor: Flinders medical centre/Flinders clinical research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-17
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1937

Inclusion Criteria

Presenting to the emergency department with:
- Clinical features in whom the treating physician seeks to measure the serum troponin level.
- Willing to give informed consent

Exclusion Criteria

- Patients with ST-segment elvation on the presenting ECG
- Inability to complete clinical history questionnaire due to language of co-morbidity.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cumulative composite endpoint of all cause mortality and new or recurrent acute coronary syndrome(ACS) measured beyond the first 24 hours of enrolment. All admissions will be evaluated for evolving ACS and myocardial infarction(MI) after admission using clinical assessment data and test results. All biomarker elevations will be referred for MI adjudication and assessed in a blinded manner to confirm time of criteria and timing of event.[30 days, 6 months and 12 months]